back in Oct 2020 -> "an early Moderna (MRNA) investor and Harvard PhD, Timothy Springer, continued to pour his fortune into this small cap stock. Mr. Springer also happens to be a director at Selecta Biosciences. He reportedly purchased more than 6,500,000 shares in October. He went on a shopping spree on October 7 when he bought 654,953 shares at $1.65 and continued buying all the way to October 23 when he bought 994,448 shares for $2.71."
评论:
daily chart for the initial entry
